Tuesday, July 18, 2017 11:46:30 AM
While HPPI compensates Jason for covering the company and publishing updated reports, I was just happy to finally see this little company get some coverage a year ago.
I guess my point of this post is that if someone is looking to read some pretty detailed reports on HPPI and the outlook for the company, one can check out Jason's subscription site now and see 5 or 6 reports on HPPI.
Lastly, fwiw, Jason is also a shareholder in the company...he covers a lot of biotechs on his website(s) but isn't a shareholder of all of them. So take that fwiw I suppose.
Note, I don't work with Jason or anything, but an underfollowed name like HPPI needs all the help it can get in educating investors about its story and share price potential, assuming the FDA doesn't pull a fast one on the company.
If the FDA essentially green lights the company to file for approval in BCCNS on just this single Ph. 2 trial that are in very late stages -- and if the company communicates this fact to the investment community -- then the share price should begin to perform very nicely over the next year or so, imo. If the FDA requires another confirmatory study after this one, then, ughh, smh, I'd rather not think about that.
Recent INTI News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 11:02:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 01:54:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 07:49:19 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 06:42:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 06:33:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 01:15:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM